Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients

被引:64
作者
Gando, S
Wada, H
Asakura, H
Iba, T
Eguchi, Y
Okamoto, K
Ohtomo, Y
Kawasugi, K
Koga, S
Koseki, A
Tsuji, H
Mayumi, T
Murata, A
Nakagawa, M
机构
[1] Mie Univ, Sch Med, Dept Lab Med, Tsu, Mie 5148507, Japan
[2] Hokkaido Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Sapporo, Hokkaido, Japan
[3] Kanazawa Univ, Dept Internal Med 3, Grad Sch Med Sci, Kanazawa, Ishikawa 920, Japan
[4] Juntendo Univ, Urayasu Hosp, Dept Surg, Urayasu, Japan
[5] Shiga Univ Med Sci, Intens Care Unit, Otsu, Shiga, Japan
[6] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 807, Japan
[7] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo, Japan
[8] Wakayama Med Univ, Dept Hematol Oncol, Wakayama, Japan
[9] Kawaguti Municipal Med Ctr, Dept Emergency & Crit Care Med, Kawaguchi, Japan
[10] Kyoto Prefectural Univ Med, Dept Internal Med 2, Kyoto, Japan
[11] Nagoya Univ, Grad Sch Med, Dept Emergency Med, Nagoya, Aichi, Japan
[12] Nagoya Univ, Grad Sch Med, Intens Care Unit, Nagoya, Aichi, Japan
[13] Kyorin Univ, Sch Med, Dept Trauma & Crit Care Med, Mitaka, Tokyo, Japan
[14] Iwate Med Univ, Dept Crit Care Med, Sch Med, Morioka, Iwate, Japan
关键词
DIC; ISTH; new Japanese diagnostic criteria; Japan Ministry of Health and Welfare;
D O I
10.1177/107602960501100108
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New Japanese diagnostic criteria were prepared for disseminated intravascular coagulation (DIC) in critically ill patients and their usefulness was compared with the criteria of the International Society of Thrombosis and Haemostasis (ISTH) and those of the Japan Ministry of Health and Welfare (JMHW). In a retrospective study of patients with platelet counts of less than 150 x 10(3)/mL, 52 cases (33.3%), 66 cases (42.3%), and 101 cases (64.7%) were diagnosed as DIC by the ISTH, JMHW, and new Japanese DIC criteria, respectively. The DIC state as diagnosed by the new Japanese DIC criteria included both DIC states as diagnosed by ISTH or JMHW criteria. Some DIC states diagnosed by the JMHW criteria included those diagnosed by ISHT criteria but this was not universal. The mortality of DIC as diagnosed by the ISTH or JMHW criteria was markedly high, compared to that for DIC diagnosed by the new Japanese criteria. The mortality of patients without DIC by ISTH was also high when they were diagnosed as DIC by the new Japanese criteria. The frequency of DIC by each set of diagnostic criteria was significantly higher in patients with infection than in those without infection. The mortality of DIC by each set of diagnostic criteria was significantly higher in patients with infection than in those without infection, and the mortality of overt-DIC by ISTH diagnostic criteria was also high in patients without infection.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 21 条
  • [1] A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation
    Aoki, N
    Matsuda, T
    Saito, H
    Takatsuki, K
    Okajima, K
    Takahashi, H
    Takamatsu, J
    Asakura, H
    Ogawa, N
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (05) : 540 - 547
  • [2] Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats
    Asakura, H
    Suga, Y
    Aoshima, K
    Ontachi, Y
    Mizutani, T
    Kato, M
    Saito, M
    Morishita, E
    Yamazaki, M
    Takami, A
    Miyamoto, K
    Nakao, S
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (01) : 161 - 164
  • [3] Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation
    Asakura, H
    Ontachi, Y
    Mizutani, T
    Kato, M
    Ito, T
    Saito, M
    Morishita, E
    Yamazaki, M
    Aoshima, K
    Takami, A
    Yoshida, T
    Suga, Y
    Miyamoto, K
    Nakao, S
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 67 (03) : 170 - 175
  • [4] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [5] TOWARD AN EPIDEMIOLOGY AND NATURAL-HISTORY OF SIRS (SYSTEMIC INFLAMMATORY RESPONSE SYNDROME)
    BONE, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (24): : 3452 - 3455
  • [6] Gando S, 1996, THROMB HAEMOSTASIS, V75, P224
  • [7] USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    HUANG, ME
    YE, YC
    CHEN, SR
    CHAI, JR
    LU, JX
    ZHOA, L
    GU, LJ
    WANG, ZY
    [J]. BLOOD, 1988, 72 (02) : 567 - 572
  • [8] KOBAYASHI N, 1987, BIBL HAEMATOL, V49, P265
  • [9] Levi M, 1999, THROMB HAEMOSTASIS, V82, P695
  • [10] Maruyama I, 1999, THROMB HAEMOSTASIS, V82, P718